About Steridoselabs

Steridoselabs combines BFS production capability, quality-system discipline, and confidential OEM/ODM development support for single-dose skincare programs that need stronger execution control.

Verified infrastructure facts

• 1.1 billion units of annual unit capacity
• Up to 3.8 million units of daily output
• 20,000 m² manufacturing hub in Guangzhou Huangpu
• ¥300M+ in equipment investment
• 30+ self-developed patents

Quality and manufacturing framework

The company operates with GMPC and ISO 22716 quality systems, 1 client / 1 formula development logic, and BFS aseptic filling capability for higher-control skincare production.

Next step

Continue to services, review ecosystem support, or start a discussion.